Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
8 6 7 7

+8 more TTM periods

ROE
17.32% 17.12% 16.57% 16.79%
ROA
15.30% 15.15% 14.57% 14.81%
ROIC
16.49% 15.40% 15.33% 14.51%
Return on Tangible Assets
23.83% 24.13% 21.78% 23.14%
Average Days of Receivables
55.35 55.04 55.39 47.84
Free Cash Flow per Share
9.23 8.12 6.98 6.37
Free Cash Flow
3,268.60 2,880.30 2,490.70 2,271.30
Other line items

Show all line items

Columns are period end dates